SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001193125-13-033659
Filing Date
2013-02-01
Accepted
2013-02-01 09:01:43
Documents
7
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 40-F/A d452061d40fa.htm 40-F/A 21024
2 EXHIBIT 99.1 d452061dex991.htm EX-99.1 774399
3 EXHIBIT 99.3 d452061dex993.htm EX-99.3 10110
4 EXHIBIT 99.4 d452061dex994.htm EX-99.4 9978
5 EXHIBIT 99.5 d452061dex995.htm EX-99.5 4288
6 EXHIBIT 99.6 d452061dex996.htm EX-99.6 4229
7 EXHIBIT 99.7 d452061dex997.htm EX-99.7 2486
  Complete submission text file 0001193125-13-033659.txt   827501
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 40-F/A | Act: 34 | File No.: 001-35203 | Film No.: 13564842
SIC: 2834 Pharmaceutical Preparations